Acurx Pharmaceuticals, Inc. (ACXP) scores 43 out of 100 on boothcheck's 11-model valuation framework. Verdict: Avoid The estimated fair value is $8175.19, representing a 180567% margin of safety. Quantitative score: 61/100. Qualitative score: 20/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.